Clinical trials
No Disease or Condition is Being Studied clinical trials
Below are recruiting no disease or condition is being studied clinical trials, each written for real people, not researchers. We’re tracking 18,511 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07578714Recruiting
Pilates and Body Balance: Research Study for Women
This study compares how Pilates practice affects core strength, balance, and flexibility in women. Researchers want to understand whether regular Pilates leads to better balance and flexibility than a sedentary lifestyle.
Istanbul, ZeytinburnuAges 20–45 - NCT07585760RecruitingPhase 2
Two-drug treatment for newly diagnosed myeloma with kidney problems
This trial tests a combination of two drugs, CM336 and isatuximab, for people newly diagnosed with multiple myeloma who also have kidney problems caused by the disease. The goal is to see if this combination can help control the myeloma while also improving kidney function.
TianjinAges 18–80 - NCT07583888RecruitingPhase 2/Phase 3
VABu Conditioning for Older Adults with Acute Myeloid Leukemia
This trial tests a chemotherapy regimen (VABu) combined with a stem-cell transplant for older adults (60+) with acute myeloid leukemia (a blood cancer) who previously responded well to Venetoclax-based treatment. The goal is to see if this approach improves outcomes after transplant.
Suzhou, JiangsuAges 60 years+ - NCT06722911RecruitingPhase 2
Adjuvant drug combo for EGFR-positive pancreatic cancer
This trial tests combining nimotuzumab with chemotherapy (nab-paclitaxel and gemcitabine) after surgery to prevent pancreatic cancer from returning. It is for people whose tumors have a protein called EGFR, and whose cancer was removed with clear or close margins.
Hangzhou, ZhejiangAges 18–75 - NCT06724536Recruiting
Study of gut bacteria and TKIs in chronic myeloid leukemia
This trial looks at how gut bacteria affect the way chronic myeloid leukemia (CML) patients respond to tyrosine kinase inhibitor (TKI) medications. It may help doctors understand why some people have better outcomes than others.
TorinoAges 18 years+ - NCT06724627Recruiting
AI skin check app for walk-in clinic patients
This trial tests a smartphone-based AI system that helps diagnose skin conditions. It may offer faster, more accurate diagnosis for people visiting a walk-in clinic with a skin problem.
The Bronx, New YorkAges Any age - NCT06722625Recruiting
Smartphone-Guided Care for High Blood Pressure
This study tests a program where you get care for high blood pressure through a smartphone app and video calls with a doctor, to see if it works better than usual care.
PoznanAges 18–80 - NCT06029049RecruitingPhase 4
Comparing two muscle relaxants for faster breathing tube placement
This study tests two different muscle relaxant drugs—rocuronium and succinylcholine—to see which one helps doctors place a breathing tube faster during emergency anesthesia. It may be a good fit for people who need general anesthesia for surgery and have either a high body mass index or a difficult airway.
Houston, TexasAges 18 years+ - NCT05698277Recruiting
Ultrasound to track baby heart function in heart disease
This study uses automated ultrasound measurements to track how a baby’s heart is working during pregnancy. It compares babies who have a specific congenital heart problem with babies without it, to understand what ultrasound can detect.
Sydney, New South WalesAges 18 years+ - NCT06124963RecruitingPhase 2
WX390 plus Toripalimab for STK11-mutated cervical cancer
This trial tests a combination of an experimental pill (WX390) and an immunotherapy drug (Toripalimab) for a specific type of cervical cancer that has an STK11 gene change. It aims to see if this combination can shrink tumors or slow the cancer.
Shanghai, Shanghai MunicipalityAges 18 years+ - NCT06423690Recruiting
Safety study of the EAS1 system for small lung tumors
This study tests a new system called EAS1 for people with early-stage lung cancer who are already scheduled for surgery. The goal is to see if the device is safe and works well, and it may offer a less invasive way to remove small lung tumors.
Kfar SabaAges 18–80 - NCT06726226Recruiting
Extremely preterm infant lung health study
This study follows the breathing and lung health of very early preterm babies (born before 29 weeks) for two years. It helps doctors understand and improve long-term respiratory care for these tiny infants.
SeoulAges Up to 1 week - NCT06726551Recruiting
AI to recognize key structures in ear surgery
This study uses artificial intelligence to analyze videos from ear surgeries that were done under a microscope. It aims to help doctors better identify important structures during operations.
Guangzhou, GuangdongAges 6 months–100 years - NCT06721234Recruiting
Vein thickness and inflammation in Behcet disease
This study looks at how the thickness of the femoral vein wall and certain markers of inflammation relate to Behcet disease. It may help doctors better understand and monitor the condition.
SohagAges 19–80 - NCT06725524RecruitingPhase 1
New drug for B-cell lymphoma that returned after treatment
This trial tests a new drug called JMT601 for people with a type of B-cell lymphoma that came back or didn't respond to at least two previous treatments. The drug targets a protein on the cancer cells to help your immune system fight the disease.
ShanghaiAges 18–70 - NCT06727370Recruiting
Cognitive screening for lung cancer patients
This study is testing a simple thinking and memory check for people with lung cancer. The goal is to find out how common cognitive problems are and to help doctors better support patients.
MilanAges 18–70 - NCT07569029RecruitingPhase 1
HIV vaccine with treatment break to boost immune response
This Phase 1 trial tests two new HIV vaccines (DV700P-RNA and DV701B1.1-RNA) combined with a monitored break from HIV medications in people with well-controlled HIV. The goal is to see if this approach safely strengthens the immune system's ability to fight HIV.
Birmingham, AlabamaAges 18–60 - NCT06726564RecruitingPhase 1
Study of MT027 for malignant pleural effusion
This trial tests a new drug called MT027 for people with advanced cancer that has spread to the lining around the lungs (pleura) and caused fluid buildup. The drug targets a marker on cancer cells called B7-H3. It may help control the fluid and the cancer.
BeijingAges 18 years+ - NCT07573176RecruitingPhase 3
Seltorexant for Depression in Adults and Older Adults
This study tests a new medication called seltorexant as a standalone treatment for major depression. The trial is for adults and older adults who have depression that hasn't improved with other antidepressants or who haven't tried them yet.
Bryant, ArkansasAges 18–74 - NCT07572006RecruitingPhase 1
Study of JNJ-95804306 for blood cancers that returned or didn't respond
This trial tests a new drug called JNJ-95804306 for people with certain blood cancers (like acute myeloid leukemia, myelodysplastic syndromes, or chronic lymphocytic leukemia) that have come back or stopped responding to other treatments. The goal is to see if the drug is safe and if it can help.
Indianapolis, IndianaAges 18 years+ - NCT07573111RecruitingPhase 1
QUAIL-100 for Children With Blood Cancers After Stem Cell Transplant
This study tests a new experimental treatment called QUAIL-100 in children and young adults who have had a stem cell transplant for a serious blood cancer. The treatment is designed to help the immune system fight remaining cancer cells.
Palo Alto, CaliforniaAges 1.5 years–39 years - NCT07570147RecruitingPhase 1
Safety study of ABBV-1451 infusions and injections in healthy adults
This early-stage trial tests how the body handles a new experimental drug called ABBV-1451, given as either an infusion (IV drip) or injection. Researchers want to make sure it's safe and well-tolerated in healthy volunteers before testing it in people with medical conditions.
Grayslake, IllinoisAges 18–60 - NCT07572396RecruitingPhase 2
HPV treatment with vaginal suppositories for mild cervical changes
This study tests a new vaginal medication (Dysplasix) to treat mild cervical cell changes caused by high-risk HPV. The goal is to see if this treatment can help your body clear the virus and prevent these changes from getting worse.
Shatin, New TerritoriesAges 18–65 - NCT07571200RecruitingPhase 1
Study of LY4256984 for ALS in Previous Trial Participants
This is a follow-up study for people with ALS who have already completed another Eli Lilly ALS treatment trial. Researchers want to continue testing a new drug (LY4256984) in people who tolerated the previous treatment well.
LeuvenAges 18–80
Hear when a new No Disease or Condition is Being Studied trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for no disease or condition is being studied?
- Yes. Clin2 currently lists 18,511 recruiting no disease or condition is being studied studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a no disease or condition is being studied trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a no disease or condition is being studied trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.